Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has inked technology access agreements with the National Cancer Institute and National Human Genome Research Institute, under which researchers at the two institutes will use Horizon's rAAV gene editing technology, called Genesis, to engineer human isogenic disease models.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.